Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Hyperfine secures $90M to ‘aggressively’ advance commercial expansion, fast-track AI developments

A number of investors pitched in during this series D financing round, including GV (formerly Google Ventures), Nextrans and Axiom Associates, the Guilford, Connecticut, startup said recently.

Nanox

Nanox Imaging sees stock rebound sharply following sell-off, fueled by positive FDA clearance news

The Israel-based startup had announced late Monday that its stockowners were unloading nearly 2.9 million shares, dragging the price downward. 

Thumbnail

Society of Cardiovascular Computed Tomography shares new CCTA guidance

The guidance, published in full in the Journal of Cardiovascular Computed Tomography, includes updates to previous CCTA recommendations and was designed to answer common questions.

The 10 most expensive drugs patients may give themselves

At a list price of $86,000 per month, Zokinvy is right now the costliest medication in the U.S. that patients can self-administer.

Vaccine distribution help on the way from Google

Google Cloud has launched an AI-backed technology toolkit to help government health personnel direct COVID vaccine doses and other resources where they’re most needed.

Thumbnail

Former imaging informatics researcher facing federal charges after fraudulently obtaining $1.7M grant

Lin Yang is accused of purposely hiding his ties to the Chinese government in relation to his imaging research and a tool known as "MuscleMiner."

Proactive AI-based ICU patient monitoring cleared for market

The FDA has OK’d AI software that can predict worsening condition in ICU patients up to eight hours before the falloff produces symptoms.

Thumbnail

Publicly traded radiology provider paying $750,000 to settle allegations of unsupervised imaging

Akumin Corp. allegedly administered more than 1,500 exams either without supervision or proof of such physician oversight, the DOJ said.